Key result
Women with type 2 diabetes had significantly lower subendocardial viability ratio (161%) compared to men with diabetes (178%, P<0.01) and men or women without diabetes (P<0.001).
Why the study?
Is subendocardial viability ratio reduced in women with short duration of type 2 diabetes compared to men with diabetes and healthy controls?
Cross-Sectional (n=172)
Is subendocardial viability ratio reduced in women with short duration of type 2 diabetes compared to men with diabetes and healthy controls?
Absolute Event Rate: 161% vs 178%
p-value: p=<0.01
Women with short-duration type 2 diabetes have a significantly reduced subendocardial viability ratio compared to men with diabetes and healthy controls, which may contribute to their unfavorable cardiovascular prognosis.
May indicate heightened subendocardial risk in diabetic women; leaves open prospective validation of sex-specific outcomes.
BACKGROUND: The pathophysiological perturbations underlying the unfavorable cardiovascular prognosis in women with type 2 diabetes (T2DM) remain elusive. Low subendocardial viability ratio (SEVR), an index of myocardial oxygen supply and demand, has been associated with intermediate cardiovascular risk markers and cardiovascular mortality in various populations. However, whether SEVR is associated with sex and cardiovascular risk markers in patients with T2DM remains to be clarified. METHODS: We examined 86 T2DM patients (mean age 59±10 years, 47% women, median diabetes duration 1.9 (range 0.2-5.0) years) and 86 sex- and age-matched control subjects in a cross-sectional study. SEVR was noninvasively assessed by tonometry and markers of cardiovascular risk by carotid-femoral pulse wave velocity (PWV), homeostasis model assessment of insulin resistance (HOMA2-IR), C-reactive protein, urinary albumin/creatinine ratio, and heart rate variability. RESULTS: Women with diabetes had significantly lower SEVR compared to both men with diabetes (161% ± 26% vs. 178% ± 32%, P < 0.01), women without diabetes (185% ± 24%, P < 0.001), and men without diabetes (188% ± 28%, P < 0.001). The differences remained significant after adjustment for age, systolic blood pressure, heart rate, diabetes, and smoking. SEVR was associated with PWV, HOMA2-IR, C-reactive protein, and reduced heart rate variability in patients and control subjects, but the associations became nonsignificant after adjustment for heart rate. CONCLUSIONS: SEVR is reduced in women with short duration of T2DM and associated with cardiovascular risk markers. The latter association seems to be at least partly mediated via heart rate. We hypothesize that reduced SEVR may contribute to the unfavorable cardiovascular prognosis in women with diabetes.
No takes yet. Share an insight, caveat, or question.
Laugesen et al. (2016) conducted a cross-sectional in Type 2 diabetes (n=172). Type 2 diabetes in women vs. Men with diabetes and individuals without diabetes was evaluated on Subendocardial viability ratio (SEVR) (p=<0.01). Women with type 2 diabetes had significantly lower subendocardial viability ratio (161%) compared to men with diabetes (178%, P<0.01) and men or women without diabetes (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: